CompletedPhase 1

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

United States1 participantsStarted 2007-12

Plain-language summary

Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation. It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion removal. The Tandem laser is capable of emitting multiple cryogen spurts intermittently with multiple 532/1064 nm laser pulses.This mode may reduce malformed blood vessels with a low incidence of long-term side effects.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult age 18 years and older * Diagnosis of vascular lesion Exclusion Criteria: * Age \<18 * Pregnancy * History of cutaneous photosensitivity * Any therapy to the proposed treatment sites within the previous two months * Current participation in any other investigational drug or device evaluation

What they're measuring

Laser treatment

Timeframe: 6 months

Trial details

NCT IDNCT00585338

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-10

View on ClinicalTrials.gov More Vascular Lesion trials